593 related articles for article (PubMed ID: 10711863)
21. Antiplatelet efficacy of XV459, a novel nonpeptide platelet GPIIb/IIIa antagonist: comparative platelet binding profiles with c7E3.
Mousa SA; Bozarth JM; Lorelli W; Forsythe MS; Thoolen MJ; Slee AM; Reilly TM; Friedman PA
J Pharmacol Exp Ther; 1998 Sep; 286(3):1277-84. PubMed ID: 9732389
[TBL] [Abstract][Full Text] [Related]
22. Functional relevance of the expression of ligand-induced binding sites in the response to platelet GP IIb/IIIa antagonists in vivo.
Murphy NP; Pratico D; Fitzgerald DJ
J Pharmacol Exp Ther; 1998 Aug; 286(2):945-51. PubMed ID: 9694954
[TBL] [Abstract][Full Text] [Related]
23. Reduced expression of platelet surface glycoprotein receptor IIb/IIIa at hyperthermic temperatures.
Pasha R; Benavides M; Kottke-Marchant K; Harasaki H
Lab Invest; 1995 Sep; 73(3):403-8. PubMed ID: 7564273
[TBL] [Abstract][Full Text] [Related]
24. P-selectin expression on platelets determines size and stability of platelet aggregates.
Merten M; Thiagarajan P
Circulation; 2000 Oct; 102(16):1931-6. PubMed ID: 11034941
[TBL] [Abstract][Full Text] [Related]
25. The effects of nitric oxide (NO) on platelet membrane receptor expression during activation with human alpha-thrombin.
Keh D; Gerlach M; Kürer I; Seiler S; Kerner T; Falke KJ; Gerlach H
Blood Coagul Fibrinolysis; 1996 Sep; 7(6):615-24. PubMed ID: 8899151
[TBL] [Abstract][Full Text] [Related]
26. In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blocking platelet function in plasma of patients with heparin-induced thrombocytopenia.
Mak KH; Kottke-Marchant K; Brooks LM; Topol EJ
Thromb Haemost; 1998 Dec; 80(6):989-93. PubMed ID: 9869172
[TBL] [Abstract][Full Text] [Related]
27. Anti-glycoprotein Ib causes platelet aggregation: different effects of blocking glycoprotein Ib and glycoprotein IIb/IIIa in the high shear filterometer.
O'Brien JR; Etherington MD
Blood Coagul Fibrinolysis; 1998 Sep; 9(6):453-61. PubMed ID: 9818994
[TBL] [Abstract][Full Text] [Related]
28. Evidence for selective degradation of platelet GP IIb/IIIa complex after prolonged in vitro ventricular assist.
Serna DL; King BO; Huh J; Jalal R; Tran L; Chen JC
J Investig Med; 1998 Aug; 46(6):279-83. PubMed ID: 9737089
[TBL] [Abstract][Full Text] [Related]
29. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists.
Michelson AD; Furman MI; Goldschmidt-Clermont P; Mascelli MA; Hendrix C; Coleman L; Hamlington J; Barnard MR; Kickler T; Christie DJ; Kundu S; Bray PF
Circulation; 2000 Mar; 101(9):1013-8. PubMed ID: 10704169
[TBL] [Abstract][Full Text] [Related]
30. Studies on the binding of 3H-SR121566, an inhibitor of Gp IIb-IIIa activation.
Savi P; Zamboni G; Rescanières O; Herbert JM
Thromb Haemost; 2001 Apr; 85(4):702-9. PubMed ID: 11341508
[TBL] [Abstract][Full Text] [Related]
31. Detection of activated platelets and platelet-leukocyte aggregates in horses.
Weiss DJ; Evanson OA
Am J Vet Res; 1997 Aug; 58(8):823-7. PubMed ID: 9256963
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric observations on the in vivo use of Fab fragments of a chimaeric monoclonal antibody to platelet glycoprotein IIb-IIIa.
Christopoulos C; Mackie I; Lahiri A; Machin S
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):729-37. PubMed ID: 8292722
[TBL] [Abstract][Full Text] [Related]
33. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
Shido K; Ahmad G; Hsu L; Kamiyama M
J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
[TBL] [Abstract][Full Text] [Related]
34. Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors.
Peter K; Schwarz M; Ylänne J; Kohler B; Moser M; Nordt T; Salbach P; Kübler W; Bode C
Blood; 1998 Nov; 92(9):3240-9. PubMed ID: 9787160
[TBL] [Abstract][Full Text] [Related]
35. Platelet glycoprotein IIb/IIIa receptor antagonist (abciximab) inhibited platelet activation and promoted skin flap survival after ischemia/reperfusion injury.
Kuo YR; Jeng SF; Wang FS; Huang HC; Wei FC; Yang KD
J Surg Res; 2002 Sep; 107(1):50-5. PubMed ID: 12384064
[TBL] [Abstract][Full Text] [Related]
36. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. II. Quantal activation parallels platelet capture in stir-associated microaggregation.
Frojmovic MM; Mooney RF; Wong T
Biophys J; 1994 Nov; 67(5):2069-75. PubMed ID: 7858144
[TBL] [Abstract][Full Text] [Related]
37. Flow cytometric analysis of the platelet surface area and surface density of glycoprotein IIb-IIIa of unactivated human platelets of various sizes.
Leytin V; Shapiro H; Novikov I; Radnay J
Biochem Biophys Res Commun; 1996 Sep; 226(1):94-100. PubMed ID: 8806597
[TBL] [Abstract][Full Text] [Related]
38. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
[TBL] [Abstract][Full Text] [Related]
39. Dissociation of glycoprotein IIb/IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregation.
Frelinger AL; Furman MI; Krueger LA; Barnard MR; Michelson AD
Circulation; 2001 Sep; 104(12):1374-9. PubMed ID: 11560852
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852.
Wittig K; Rothe G; Schmitz G
Thromb Haemost; 1998 Mar; 79(3):625-30. PubMed ID: 9531053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]